Hypercalcemia accompanied by hypothalamic hypopituitarism, central diabetes inspidus and hyperthyroidism

Area of Science:

• Endocrinology
• Oncology
• Metabolic Disorders

Background:

• Presents a rare case of a 24-year-old male with a hypothalamic tumor, hypopituitarism, central diabetes insipidus (DI), and hyperthyroidism.
• Investigates the complex interplay of endocrine dysfunctions contributing to significant hypercalcemia and hypernatremia.

Observation:

• The patient exhibited symptoms including nausea, polydipsia, anorexia, and fatigue, coinciding with elevated serum calcium and sodium levels.
• Laboratory results revealed suppressed parathyroid hormone (PTH) and 1alpha-dihydroxyvitamin D, with normal PTH-related protein, indicating a non-parathyroid source of hypercalcemia.
• Initial treatment with One-desamino-(8-D-arginine)-vasopressin (DDAVP) and half-saline corrected hypernatremia, but hypercalcemia persisted.

Findings:

• Concurrent hyperthyroidism was implicated in accelerating calcium release from bone.
• Hypocortisolism and central DI were considered contributing factors to altered renal calcium handling.
• Treatment with cortisone acetate and thiamazole effectively reduced serum calcium levels.

Implications:

• Highlights the importance of considering multiple endocrine disorders in the differential diagnosis of hypercalcemia.
• Demonstrates the potential impact of concurrent hyperthyroidism and pituitary dysfunction on calcium metabolism.
• Suggests a multimodal treatment approach for complex cases of hypercalcemia associated with hypothalamic tumors and autoimmune conditions.